Kably AA, Ruiz AJ, Sánchez LA

Language: Spanish
References: 16
Page: 291-299
PDF size: 272.38 Kb.

ABSTRACT

Background: The ovarian hyperstimulation syndrome is a serious complication in patients who undergo controlled ovarian stimulation and for that reason all clinicians who prescribe ovulation inducing agents must be prepared to recognize and manage ovarian hyperstimulation syndrome, to prevent severe and ocasionally mortal complications.
Objective: To communicate the experience in the treatment of ovarian hyperstimulation syndrome as a complication in patients who undergo controlled ovarian stimulation.
Patients and methods: In the present study seven patients who developed severe ovarian hyperstimulation syndrome were included, and were treated by ultrasound guided paracentesis and self-transfusion of the ascitic fluid.
Results: In all patients we observed a clinical improvement immediatly after the drainage of ascitic fluid no hematological or infectious disease were observed after the self-transfusion. We observed a reduction in hemoglobin of 20.9% and 22.2% in the hematocrit after paracentesis and self-transfusion, meanwhile we observed an increase of 55.5% in the albumin level. Any patient developed hemodynamic disturbance after paracentesis after drainage of great volume in the paracentesis (mean of 4453.4 mL per patient).
Conclusions: The drainage of ascitis by paracentesis and self-transfusion of the fluid is a good therapeutic option in patients with severe ovarian hyperstimulation syndrome in combination with intravenous fluids and administration of human albumin 25%.

REFERENCES

1. Rizk B, Aboulghar M. Modern management of ovarian hyperstimulation syndrome. Hum Reprod 1991;6:1082-7.

2. Brinsden PR, Wada I, Tan SL, Balen A, Jacobs HS. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995;102:767-72.

3. Goldsman MP, Pedram A, Dominguez CE. Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertil Steril 1995;63:268-72.

4. McClure N, Healy DL, Rogers PA, et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994;344:235-6.

5. Levin ER, Rosen GF, Cassidenti DL, et al. Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome. J Clin Invest 1998;102:1978-85.

6. Artini PG, Monti M, Fasciani A, et al. Factor de crecimiento del endotelio vascular, interleucina-6 e interleucina-2 en suero y líquido folicular del paciente con el síndrome de hiperestimulación ovárica. Eur J Obstet Gynecol 2002;2:300-5.

7. Paulson RJ, Do YS, Hsueh WA, Eggena P, Lobo RA. Ovarian renin production in vitro and in vivo: characterization and clinical correlation. Fertil Steril 1989;51:634-8.

8. Balash J, Fabregues F, Arroyo V. Peripheral arterial vasodilation hypothesis: a new insight into pathogenesis of ovarian hyperstimulation syndrome. Hum Reprod 1998;13:2718-30.

9. Mathur RS, Akande AV, Keay SD, Hunt LP, Jenkins JM. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 2000;73:901-7.

10. The Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril 2004;82(suppl1):S81-S86.

11. Moris R. Ovarian hyperstimulation syndrome: classification and management. Obstet Gynecol 1994;23:43-54.

12. Chin-Der C, Jehn Hsiahn Y, Kuang-Han C. Effects of repeated abdominal paracentesis on uterine and intraovarian haemodynamics and pregnancy outcome in severe ovarian hyperstimulation syndrome. Hum Reprod 1998;13:2077-81.

13. Aboulghar MA, Mansour RT, Serour GL, et al. Segment of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive intravenous fluid therapy. Obstet Gynecol 1993;81:108-11.

14. Aboulghar M, Mansour R, Serour G, Riad R. Autotransfusion of the ascitic fluid in the treatment of severe ovarian hyperstimulation syndrome. Fertil Steril 1992;58:1056-9.

15. Fukaya T, Chida S, Terada Y, Funayama Y. Treatment of severe ovarian hyperstimulation syndrome by ultrafiltration and reinfusion of ascitic fluid. Fertil Steril 1994;61:561-4.

16. Levin I, Almog B, Avni A, et al. Effect of paracentesis of ascitic fluids on urinary output and blood indices in patients with severe ovarian hyperstimulation syndrome. Fertil Steril 2002;77:986-8.